OBJECTIVE To Address challenges in clinical care, quality improvement, research, and
public policy for prenatally opioid-exposed neonates by standardizing the clinical definition …

The incidence of infant opioid withdrawal has grown rapidly in many countries, including
Canada, in the last decade, presenting significant health and early brain development …

BACKGROUND: As rates of neonatal opioid withdrawal are increasing, the need for
research to evaluate new treatments is growing. Large heterogeneity exists in health …

OBJECTIVES: The incidence of infants born exposed to opioids continues to rise.
Historically, newborns with neonatal abstinence syndrome have been treated with …

Neonates who have had in utero exposures from maternal substance abuse can experience
central nervous system effects of the drugs, including drug toxicity and withdrawal. Neonatal …

Tens of thousands of infants are impacted yearly by prenatal opioid exposure. The term
neonatal opioid withdrawal syndrome (NOWS) is now replacing the more familiar term …

The opioid crisis has grown to affect pregnant women and infants across the United States,
as evidenced by rising rates of opioid use disorder among pregnant women and neonatal …

A significant number of advances have been made in the last 5 years with respect to the
identification, diagnosis, assessment, and management of infants with prenatal opioid …

METHODS: Data for this retrospective cohort study were obtained from opioid-exposed
infants born at Vanderbilt University Medical Center in 2018. Six commonly used clinical and …

As the prescription opioid epidemic grew in the USA, its impact extended to pregnant
women and their infants. This review summarises how increasing rates of neonatal …